-
Machine Learning Predicts mRNA Vaccine LNPs
2026-08-17
Wang and colleagues developed a LightGBM model that predicted the immunogenic performance of lipid nanoparticle mRNA vaccine formulations and identified influential ionizable-lipid substructures. Experimental comparison of MC3 and SM-102, together with molecular dynamics modeling, showed how computational screening can prioritize formulations while clarifying nanoparticle–mRNA organization.
-
Nadolol (SQ-11725) Workflows for Cardiovascular Research
2026-08-16
Build reproducible Nadolol assays that connect non-selective beta-adrenergic blockade with transporter-aware pharmacokinetics. This workflow combines pathway profiling, OATP1A2 studies, and disease-state controls for hypertension research, angina pectoris studies, and vascular headache research.
-
Cy5 maleimide (non-sulfonated) Workflow Guide
2026-08-15
Cy5 maleimide (non-sulfonated), SKU A8139, provides a thiol-selective route for fluorescent labeling of peptides and proteins that contain accessible cysteine residues. It should not be selected for proteins lacking free thiols or workflows that require an aqueous-only reagent because the dye has low aqueous solubility.
-
HITT Regulation of ATM and Homologous Recombination
2026-08-15
The reference study identifies the long noncoding RNA HITT as a direct inhibitor of ATM activation after DNA double-strand breaks. By limiting MRN-dependent ATM recruitment and homologous recombination repair, HITT increases cancer-cell sensitivity to DNA-damaging treatment and provides a mechanistic framework for studying DNA damage response inhibition.
-
PX-478 in Prenatal Hypoxia–Linked ASD Models
2026-08-14
A 2024 rat study found that PX-478 reduced autism-like behavioral abnormalities after prenatal hypoxia and was associated with lower hippocampal HIF-1α, lower serum VEGF, and higher PTEN protein. The work provides a mechanistic framework for studying hypoxia-responsive signaling in neurodevelopment, while its early-treatment toxicity findings emphasize the need for age- and exposure-specific validation.
-
SB 431542: ALK5 Inhibition in Neuroimmune Assays
2026-08-14
SB 431542 is a selective ALK5 inhibitor for dissecting TGF-β-dependent Smad2 signaling, neuronal injury, glioma growth, and immune modulation. This workflow translates emerging M1-macrophage–exosome findings into practical pathway-causality experiments while emphasizing dose selection, controls, and assay-specific troubleshooting.
-
ddATP Workflows for DNA Synthesis Termination
2026-08-13
ddATP converts nucleotide incorporation into a controllable chain-termination event, enabling practical workflows from Sanger sequencing to polymerase and repair assays. This guide connects substrate-competition experiments with the oocyte double-strand-break study, emphasizing dose design, orthogonal readouts, and troubleshooting.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-08-13
Build more interpretable transient-expression experiments with a Cap1- and poly(A)-optimized firefly luciferase transcript. This guide shows how to use it as a delivery control, translation benchmark, pathway companion, and in vivo imaging reporter while avoiding ATP, viability, and transcriptional readout confounders.
-
Fluorouracil: An Evolution-Aware Assay Strategy
2026-08-12
Fluorouracil research is more informative when drug response is interpreted alongside tumor evolution. This article connects 5-Fluorouracil mechanism, colorectal cancer heterogeneity, and practical assay design without confusing a cell-line IC50 with a universal biomarker.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-08-12
Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic response triggered by depletion of hypophosphorylated RNA Pol IIA, rather than through passive loss of transcripts. Their PDAR framework connects RNA Pol II degradation to mitochondrial death signaling and provides a mechanistic lens for interpreting transcription-targeting drugs.
-
Proteinase K for EV Cargo and DNA Workflows
2026-08-11
Proteinase K is more than a routine digestion reagent: it can help separate extracellular-vesicle surface effects from protected cargo while supporting high-integrity DNA workflows. This article connects Proteinase K assay design with recent Candida albicans EV research and defines the controls needed for defensible interpretation.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-10
HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an enzymatic detection route for rabbit primary antibodies in Western blotting, ELISA, IHC, and IC. It should be selected when the primary antibody is rabbit-derived and the assay is compatible with HRP substrates; it is for research use only and should not be used for diagnostic or medical applications.
-
miR-424/503, CDC25A, and TGF-β Cell-Cycle Arrest
2026-08-09
The reference study identifies the miR-424/503 cluster as a posttranscriptional effector of TGF-β-induced cytostasis in mammary epithelial cells. By combining genetic perturbation, RNA-silencing assays, reporter systems, and in vivo analysis, it shows that microRNA-mediated CDC25A repression cooperates with transcriptional silencing and protein degradation to enforce G1 arrest.
-
ABT-263: A Mechanism-First Apoptosis Tool
2026-08-08
ABT-263 (Navitoclax) is a powerful probe for mitochondrial apoptosis, but its greatest value emerges when endpoint data are interpreted mechanistically. This guide integrates Bcl-2 family biology with the 2025 RNA Pol II degradation-dependent apoptosis study to improve apoptosis assay design and cancer-model interpretation.
-
Spiroplasma Entry Routes in Drosophila S2 Cells
2026-08-07
Wei et al. established a Drosophila Schneider 2 cell model to define how Spiroplasma eriocheiris enters and proliferates within insect cells. Their inhibitor-based experiments identify clathrin-mediated endocytosis and macropinocytosis, but not caveola-associated uptake, as major entry routes and connect infection with actin and microtubule function.
456 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page